Work

Burden of Disease due to Nonalcoholic Fatty Liver Disease

Year: 2020

Type: review

Source: Gastroenterology Clinics of North America

DOI: 10.1016/j.gtc.2019.09.007

Authors: Mark D. Muthiah, Arun J. Sanyal

Institutions: National University of Singapore, National University Hospital, National University Health System, Virginia Commonwealth University, Virginia Commonwealth University Medical Center

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Merck, Novartis, Gilead Sciences, Shire, Intercept Pharmaceuticals, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Salix Pharmaceuticals

Award: LIPIDOMICS BASED DIAGNOSTICS FOR NONALCOHOLIC STEATOHEPATITIS

OpenAlex ID: W3004467589

FWCI: 1.823

Cites: 150

Cited by: 66

Related to: 10